Carla Arnau del Valle

Carla Arnau del Valle

Auto-generated profile, based on publicly available information

Carla Arnau del Valle

Fischell Department of Bioengineering College Park University of Maryland Maryland USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 April 2022 in Photochemical & Photobiological Sciences
Verified
Journal Article
Open access
PDF file
BTBrydie A. Thomas-Moore
Brydie A. Thomas-Moore
CVCarla Arnau del Valle
Carla Arnau del Valle
RFRobert Field
Robert Field
MMMaría J. Marín
María J. Marín
The rise of antibacterial drug resistance means treatment options are becoming increasingly limited. We must find ways to tackle these hard-to-treat drug-resistant and biofilm infections. With the lack of new antibacterial drugs (such as antibiotics) reaching the clinics, research has switched focus to exploring alternative strategies. One such strategy is antibacterial photodynamic therapy (aPDT), a system that relies on light, oxygen, and a non-toxic dye (photosensitiser) to generate cytotoxic reactive oxygen species. This technique has already been shown capable of handling both drug-resistant and biofilm infections but has limited clinical approval to date, which is in part due to the low bioavailability and selectivity of hydrophobic photosensitisers. Nanotechnology-based techniques have the potential to address the limitations of current aPDT, as already well-documented in anti-cancer PDT. Here, we review recent advances in nanoparticle-based targeting tactics for aPDT. Graphical

11 May 2022 in Methods and Applications in Fluorescence
Verified
Journal Article
Open access
CVCarla Arnau del Valle
Carla Arnau del Valle
Thomas HirschThomas Hirsch
Thomas Hirsch
MMMaría J Marín
María J Marín
Photodynamic therapy (PDT) is a well-established treatment of cancer that uses the toxic reactive oxygen species, including singlet oxygen (1O2), generated by photosensitiser (PS) drugs following irradiation of a specific wavelength to destroy the cancerous cells and tumours. Visible light is commonly used as the excitation source in PDT, which is not ideal for cancer treatment due to its reduced tissue penetration, and thus inefficiency to treat deep-lying tumours. Additionally, these wavelengths exhibit elevated autofluorescence background from the biological tissues which hinders optical biomedical imaging. An alternative to UV–Vis irradiation is the use of near infrared (NIR) excitation for PDT. This can be achieved using upconverting nanoparticles (UCNPs) functionalised with photosensitiser drugs where UCNPs can be used as an indirect excitation source for the activation of PS drugs yielding to the production of singlet 1O2 following NIR excitation. The use of nanoparticles for PDT is also beneficial due to their tumour targeting capability, either passively via the enhanced permeability and retention (EPR) effect or actively via stimuli-responsive targeting and ligand-mediated targeting (i.e. using recognition units that can bind specific receptors only present or overexpressed on tumour cells). Here, we review recent advances in NIR upconverting nanomaterials for PDT of cancer with a clear distinction between those reported nanoparticles that could potentially target the tumour due to accumulation via the EPR effect (passive targeting) and nanoparticle-based systems that contain targeting agents with the aim of actively target the tumour via a molecular recognition process.

3 November 2021 in Dalton Transactions
Verified
Journal Article
Open access
PDF file
HMHanna K. Maliszewska
Hanna K. Maliszewska
CVCarla Arnau del Valle
Carla Arnau del Valle
YXYing Xia
Ying Xia
MMMaría J. Marín
María J. Marín
ZWZoё Waller
Zoё Waller
MMMaría Paz Muñoz
María Paz Muñoz
Bis(pyridyl)allenes: unique 3D scafolds for novel metal coordination complexes with unreported applications in catalysis and as metallodrugs.

8 March 2023 in Journal of Materials Chemistry B
Verified
Journal Article
Open access
PDF file
CVCarla Arnau del Valle
Carla Arnau del Valle
PTPaul Thomas
Paul Thomas
FGFrancisco Galindo
Francisco Galindo
MMMaría Paz Muñoz
María Paz Muñoz
MMMaría J. Marín
María J. Marín
Nitric oxide (NO) plays an important role in the regulation of the immune, cardiovascular and nervous systems. Consequently, being able to monitor and quantify intracellular NO levels would provide a greater understanding of the implications of this molecule in the different biological processes, including, for example, in cancer. Here, we report a broadly applicable two-photon excitable fluorescent nanoprobe able to detect and potentially quantify NO levels in an extensive range of cellular environments. The nanoprobe consists of a thiolated photoinduced electron transfer-based two=photon fluorescent probe attached onto the surface of 2.4 ± 0.7 nm gold nanoparticles (DANPY-NO@AuNPs). The nanoprobe, which can be synthesised in a reproducible manner and exhibits great stability when stored at room temperature, is able to selectively detect NO in solution, with a dynamic range up to 150 μM, and at pH values of biological relevance. DANPY-NO@AuNPs were able to selectively detect endogenous NO in RAW264.7γ NO− macrophages and THP-1 human leukemic cells; and endogenous and exogenous NO in endothelial cells. The nanoprobe accumulated in the acidic organelles of the tested cell lines showing negligible toxicity. Importantly, DANPY-NO@AuNPs showed potential to quantify intracellular NO concentrations in MDA-MB-231 breast cancer cells. The biological evaluation of the nanoprobe was undertaken using confocal laser scanning (images and intracellular emission spectra) and multiphoton microscopies, and flow cytometry. Based on their excellent sensitivity and stability, and outstanding versatility, DANPY-NO@AuNPs can be applied for the spatiotemporal monitoring of in vitro and in vivo NO levels.

14 May 2025 in Bioengineering & Translational Medicine
Verified
Journal Article
Open access
CVCarla Arnau del Valle
Carla Arnau del Valle
PSPayal Srivastava
Payal Srivastava
KMKathryn McNaughton
Kathryn McNaughton
HHHuang Chiao Huang
Huang Chiao Huang
Photodynamic therapy (PDT) is a minimally invasive treatment that involves the administration of a light‐activatable drug followed by light activation of the lesion to produce reactive oxygen species that kill cancer cells. Visudyne®, a liposomal formulation of benzoporphyrin derivative (BPD) photosensitizer, is clinically approved for PDT of ocular diseases and is now being tested for PDT and imaging of pancreatic, brain, and other cancers. While Visudyne® improves the pharmacokinetics of BPD, it lacks treatment selectivity. To reduce PDT‐associated side effects such as skin and bowel toxicity while enhancing therapeutic outcomes, developing cancer‐targeted BPD nanotechnology is essential. Many cancers are characterized by overexpression of folate receptor (FR) and present high levels of glutathione (GSH). Here, we report the synthesis of a dimeric‐BPD (dBPD) activatable by red light for PDT and imaging of cancer cells. Self‐assembled lipid nanoparticles (NPs) are developed by the aggregation of dBPD and further functionalized with FA (FA‐dBPD‐NPs) and with drug release capability via cleavage of the disulfide linkers through GSH. The FA‐dBPD‐NPs present high drug payload, GSH‐triggered release effect, FRs overexpressing cell targeting, endoplasmic reticulum accumulation, and effective PDT in ovarian cancer cells.

5 October 2026
Verified
Preprint
Open access
PDF file
CVClara Vazquez-Martel
Clara Vazquez-Martel
STSANDRA TRUJILLO
SANDRA TRUJILLO
CVCarla Arnau del Valle
Carla Arnau del Valle
LSLea Sielaff
Lea Sielaff
Juan Luis Gomez PinchettiJuan Luis Gomez Pinchetti
Juan Luis Gomez Pinchetti
Eva BlascoEva Blasco
Eva Blasco
Photodynamic therapy (PDT) offers localized, controllable cancer treatment through reactive oxygen species (ROS) generated by light-activated photosensitizers. Three-dimensional (3D) printing of PDT-active materials has emerged as a powerful tool for fabricating customized structures with controlled architecture and composition. However, conventional PDT materials often require complex, multi-step syntheses with low yields. Consequently, integrating natural photosensitizers into biocompatible matrices represents a crucial step towards sustainable PDT. Here, microalgae-derived materials are investigated to fabricate high-resolution scaffolds via 3D laser printing while retaining the intrinsic photoactive properties of chlorophyll. Within these matrices, native chlorophyll derivatives fulfill a triple light-induced function: driving microalgal lipid biosynthesis, initiating additive-free 3D laser printing, and acting as immobilized photosensitizers. Fluorometric assays confirm robust ROS generation upon red-light irradiation of the 3D printed microalgae-derived material. The photodynamic efficacy of these scaffolds is evaluated in melanoma cells to demonstrate their therapeutic potential. In vitro studies reveal significantly reduced cell viability upon irradiation, while maintaining cytocompatibility under dark conditions. Furthermore, the microalgae-derived materials enable the fabrication of scaffolds with varied complex geometries and feature sizes while retaining photodynamic activity. These findings demonstrate a highly versatile, biobased strategy combining natural photosensitizers with 3D laser printing to produce functional platforms for precision PDT.